CellRapeutics™ Leukopak from Solid Tumor Cancer Donor (XS-0426-XU289)

Name: CellRapeutics™ Leukopak from Solid Tumor Cancer Donor
SKU: XS-0426-XU289
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

This Leukopak is procured from donors with diverse histologies of solid malignancies. The cellular pool is characterized by a systemic pro-tumorigenic environment, including increased immunosuppressive checkpoints and tumor-educated monocytes. It provides a robust, large-scale source of primary cells for the development of pan-cancer immunotherapies and the investigation of systemic cancer-related inflammation.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Solid Tumor Cancer Donor

Cat. No.
XS-0426-XU289

Donor Age
Middle-Aged, Senior

Donor Health
Clinically diagnosed with various solid malignancies. The leukocyte repertoire is marked by tumor-host dynamics, featuring systemic signatures of immunosuppressive cell expansion and anti-tumor effector populations.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, optimized for broad-spectrum preservation of tumor-reactive T cell subsets and myeloid-derived cells.

Additional Donor Information
Each lot features a Leukopak from donors with various solid malignancies. Profiles categorize tumor site and stage, providing a robust base for pan-cancer immunotherapy and biomarker discovery research.

Clinical Profile
Primary tumor site and histology, stage of malignancy, history of systemic therapies, and current disease status.

Additional Information

Medication History
Available upon request. Detailed history of cytotoxic chemotherapy, targeted biologicals, immune checkpoint inhibitors, and previous radiation therapy.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Solid Tumor Cancer Donor, Leukopak, Solid Tumor Cancer

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Solid Tumor Cancer Donor (XS-0426-XU289). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.